Employer
University Hospitals Coventry and Warwickshire NHS Trust
Job Overview
This 12-month Advanced Clinical Training Fellowship in Multiple Sclerosis and Neuroinflammatory Disease provides neurology trainees within 12 months of CCT or completion of specialist training with advanced subspecialty training. Fellows will work in a tertiary neurosciences service, gaining expertise in diagnosing and managing inflammatory neurological disorders including multiple sclerosis, neurosarcoidosis, neuromyelitis optica spectrum disorders, MOG antibody-associated disease, autoimmune encephalitis, CNS vasculitis and related neuroimmunological conditions.
The programme includes training in disease-modifying therapy prescribing and monitoring, escalation therapies and biologic treatments, and multidisciplinary neurorehabilitation services. Fellows will also be encouraged to participate in clinical research, national registries, audit and quality improvement activities, and contribute to clinical trials and service development initiatives.
Responsibilities
- Participate in specialist MS and neuroinflammatory disease outpatient clinics.
- Assess and manage patients with relapsing and progressive MS and other neuroinflammatory disorders.
- Develop expertise in disease-modifying therapy selection, initiation and monitoring.
- Participate in neuroimmunology multidisciplinary team meetings.
- Contribute to inpatient neurological consultations involving inflammatory neurological disease.
- Gain experience in the interpretation of neuroimaging, CSF analysis and immunological investigations relevant to neuroinflammatory disease.
- Participate in relapse management services and infusion therapy pathways.
- Contribute to patient education, service development and shared decision making.
- Participate in teaching, audit, research and quality improvement activities.
Qualifications
- Neurology trainee within 12 months of CCT or within 12 months of completion of specialist training.
- Interest in advanced subspecialty training in the diagnosis and management of inflammatory neurological disorders.
#J-18808-Ljbffr…